Efficacy of Low-Protein Rice for Dietary Protei???????n Restriction in CKD Patients: A Multicenter, Randomized, Controlled Study

被引:4
|
作者
Hosojima, Michihiro [1 ]
Kabasawa, Hideyuki [1 ]
Kaseda, Ryohei [2 ]
Ishikawa-Tanaka, Tomomi [2 ]
Obi, Yoshitsugu [3 ]
Murayama, Toshiko [2 ]
Kuwahara, Shoji [4 ]
Suzuki, Yoshiki [2 ]
Narita, Ichiei [2 ]
Saito, Akihiko [4 ]
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Kidney Res Ctr, Dept Clin Nutr Sci,Chuo Ku, 1-757 Asahimachi Dori, Niigata, Niigata 9518510, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Kidney Res Ctr, Div Clin Nephrol & Rheumatol,Chuo Ku, 1-757 Asahimachi Dori, Niigata, Niigata 9518510, Japan
[3] Univ Mississippi, Div Nephrol, Med Ctr, Jackson, MS USA
[4] Niigata Univ, Grad Sch Med & Dent Sci, Kidney Res Ctr, Dept Appl Mol Med,Chuo Ku, Niigata, Niigata, Japan
来源
KIDNEY360 | 2022年 / 3卷 / 11期
关键词
clinical nephrology; chronic kidney disease; clinical trial; low protein diet; low-protein rice; protein-restricted diet; PROGRESSION; DISEASE;
D O I
10.34067/KID.0002982022
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background The benefits of dietary protein restriction in CKD remain unclear, largely due to inadequate adherence in most clinical trials. We examined whether low-protein rice (LPR) previously developed to reduce the protein content of rice, a major staple food, would help improve adherence to dietary protein restriction. Methods This open-label, multicenter, randomized, controlled trial evaluated the efficacy of LPR use for reducing dietary protein intake (DPI) in patients with CKD stages G3aA2-G4. Participants were randomly assigned in a 1:1 ratio to an LPR or control group and were followed up for 24 weeks. Both groups received regular counseling by dietitians to help achieve a target DPI of 0.7 g/kg ideal body weight (IBW) per day. The amount of protein in LPR is about 4% of that in ordinary rice, and the participants in the LPR group were instructed to consume LPR with at least two meals per day. The primary outcome was estimated dietary protein intake (eDPI) determined using the Maroni formula. The secondary outcomes included creatinine clearance (CCr) and urinary protein on the basis of 24-hour urine collection. Results In total, 51 patients were randomized to either the LPR group or the control group. At baseline, mean age was 62.5 years, 70% were men, mean CCr was 52.0 ml/min, and mean eDPI was 0.99 g/kg IBW per day. At 24 weeks, mean eDPI decreased to 0.80 g/kg IBW per day in the LPR group and to 0.91 g/kg IBW per day in the control group, giving a between-group difference of 0.11 g/kg IBW per day (95% confidence interval, 0.03 to 0.19 g/kg IBW per day; P=0.006). There was no significant between-group difference in CCr, but urinary protein was lower at 24 weeks in the LPR group than in the control group. Conclusions LPR is a feasible tool for efficiently reducing DPI in patients with CKD.
引用
收藏
页码:1861 / 1870
页数:10
相关论文
共 50 条
  • [41] Enzobiotics-A Novel Therapy for the Elimination of Uremic Toxins in Patients with CKD (EETOX Study): A Multicenter Double-Blind Randomized Controlled Trial
    Saxena, Anita
    Srinivasa, Sanjay
    Veerappan, Ilangovan
    Jacob, Chakko
    Mahaldar, Amol
    Gupta, Amit
    Rajagopal, Ananthasubramaniam
    NUTRIENTS, 2022, 14 (18)
  • [42] Randomized, Placebo-Controlled, Multicenter Clinical Study on the Efficacy and Safety of Lidocaine Patches in Chinese Patients with Postherpetic Neuralgia
    Wang, Aiping
    Li, Hang
    Xie, Zhihong
    Li, Lingfeng
    Jiang, Xian
    Guo, Qing
    Hu, Fengming
    Zhang, Jianzhong
    Cui, Yong
    Ding, Yangfeng
    Fang, Hong
    Han, Xiuping
    Guo, Shuping
    Wang, Junlong
    Ni, Na
    DERMATOLOGY AND THERAPY, 2023, 13 (07) : 1477 - 1487
  • [43] Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease
    Shunsuke Goto
    Kentaro Nakai
    Keiji Kono
    Yuriko Yonekura
    Jun Ito
    Hideki Fujii
    Shinichi Nishi
    Clinical and Experimental Nephrology, 2014, 18 : 925 - 931
  • [44] The efficacy of different treatment approaches for pediatric OSAHS patients with mandibular retrognathia: study protocol for a multicenter randomized controlled trial
    Yuanyuan Li
    Jiali Wu
    Jinghan Guo
    Liming Yu
    Jing Wang
    Xiaoyan Li
    Shuhua Xu
    Min Zhu
    Jinqiu Feng
    Yuehua Liu
    Trials, 21
  • [45] Efficacy of methotrexate and etanercept biosimilar rhTNFR:Fc in Chinese patients with active rheumatoid arthritis: A controlled, randomized and multicenter study
    Wu, Qingjun
    Zhao, Yan
    Xu, Dong
    Zhang, Zhuoli
    Li, Zhenbin
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [46] The efficacy of different treatment approaches for pediatric OSAHS patients with mandibular retrognathia: study protocol for a multicenter randomized controlled trial
    Li, Yuanyuan
    Wu, Jiali
    Guo, Jinghan
    Yu, Liming
    Wang, Jing
    Li, Xiaoyan
    Xu, Shuhua
    Zhu, Min
    Feng, Jinqiu
    Liu, Yuehua
    TRIALS, 2020, 21 (01)
  • [47] Efficacy and safety of oxcarbazepine in patients with migraine headaches: A multicenter, double. blind, randomized, placebo-controlled study
    Saper, J
    Silberstein, S
    Somogyi, M
    McCague, K
    NEUROLOGY, 2005, 64 (06) : A334 - A334
  • [48] The efficacy of Combizym in the treatment of Chinese patients with dyspepsia: a multicenter, randomized, placebo-controlled and cross-over study
    Ran, Zhi Hua
    Yuan, Yao Zong
    Li, Zhao Shen
    Wang, Ji Yao
    Zong, Chun Hua
    Xie, Wei Fen
    Zheng, Ping
    Chen, Sheng Liang
    Zhan, Xian Bao
    Chen, Shi Yao
    Xiao, Shu Dong
    JOURNAL OF DIGESTIVE DISEASES, 2009, 10 (01) : 41 - 48
  • [49] Efficacy and safety of oral sulfate tablet for the bowel preparation in patients with inflammatory bowel disease: multicenter randomized controlled study
    Kim, K. O.
    Jang, B. I.
    Lee, Y. J.
    Lee, H. S.
    Kim, E. S.
    Jung, Y. J.
    Kim, E. Y.
    Kim, S. K.
    Yang, C. H.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I282 - I283
  • [50] Efficacy and Safety of Diclofenac plus Capsaicin Gel in Patients with Acute Back/Neck Pain: A Multicenter Randomized Controlled Study
    Predel, Hans-Georg
    Ebel-Bitoun, Caty
    Peil, Barbara
    Weiser, Thomas W.
    Lange, Robert
    PAIN AND THERAPY, 2020, 9 (01) : 279 - 296